Company FAVEA plans to develop a dozen of new pharmaceutical projects in accordance with standard GMP and put into operation five new pharmaceutical productions.
FAVEA, one of the leading companies in the pharmaceutical industry, undergo several changes in year 2009. Our company is well-known on Russian and Ukrainian markets by the implementation and financing of major projects on reconstruction of production facilities in compliance with GMP standards in such enterprises as Pharmstandard, Nizhpharm, Tatkhimpharmpreparaty, BHFZ, Darnitsa and others.
The FAVEA company registered in the beginning of year 2009 its subsidiary in Ukraine, known as «FAVEA engineering Kiev». This logical step has been taken by a desire to strengthen the position of FAVEA on the Ukrainian market, to expand the range of services provided to pharmaceutical manufacturers in Ukraine. In particular, «FAVEA engineering Kiev» will manage new contracts for projecting and engineering services with the possibility of payment in local currency - UAH.
In the first half of May, President of Georgia Mikheil Saakashvili visited the capital city of the Czech Republic in the context of summit “European Union - Eastern Europe”. During this visit a business lunch with the President of Georgia and the representatives of the leading Czech companies working in Georgia was held. FAVEA was among the members at this meeting with Mr. Saakashvili. Currently FAVEA starts realization of a comprehensive modernization of the Blood Center in Tbilisi. The owner of this project is a Georgian company Express Diagnostic.
On Jun 17th, 2008 in Ufa OAO “Pharmstandard-Ufavita” officially opened a new aseptic pharmaceutical production of drugs, where will be produced the first growth hormone product in Russian Federation – RASTAN. The project, construction, installation of the clean rooms...
This year “Platinum Ounce” award in the special category of the organizing committee for the “Successful implementation of projects on modernization of pharmaceutical production in Russian Federation in accordance with the standards GMP” received company FAVEA
Video
Opening of a new pharmaceutical production in Kazan
The new production of growth hormone RASTAN in Ufa
The worldwide most important document in determining the requirements for production and quality control of medicines for humans and animals is "Good Manufacturing Practice for Medicinal Products (GMP)".
Validation
In the methodological guidance we take into account the most recent issues of the national normative documents, the recommendations of the World Health Organization (WHO) and the Convention on mutual recognition of inspections in ...
GMP Training
The purpose of this training is to deepen the fundamental knowledge and expertise on the development of modern pharmaceuticals, manufacturing and quality control. Important objective is to train the personnel, ...
